Analysts initiate coverage on Abbott, LivaNova, Amplitude, Lionsgate, Honeywell
Top Wall Street analysts initiated coverage on Abbott Laboratories, LivaNova PLC, Amplitude Inc, Lionsgate Studios Corp, and Honeywell Aerospace Inc. Baird rated Abbott Laboratories Outperform with a $121 target, while Freedom Capital Markets placed a Hold rating on LivaNova PLC with an $81 target. Raymond James initiated Amplitude Inc with a Strong Buy rating and $10 target, B. Riley Securities rated Lionsgate Studios Corp Neutral with a $17 target, and Wells Fargo initiated Honeywell Aerospace Inc with an Equal-Weight rating and $250 target.
*this image is generated using AI for illustrative purposes only.
Top Wall Street analysts initiated coverage on several major companies, including Abbott Laboratories, LivaNova PLC, Amplitude Inc, Lionsgate Studios Corp, and Honeywell Aerospace Inc. The ratings and price targets provide new guidance for investors regarding these stocks. Abbott shares closed at $90.74 on Tuesday, while LivaNova shares closed at $82.23. Amplitude, Lionsgate Studios, and Honeywell Aerospace closed at $7.65, $15.31, and $221.08 respectively.
Abbott Laboratories
Baird analyst David Rescott initiated coverage on Abbott Laboratories with an Outperform rating and a price target of $121.
LivaNova PLC
Freedom Capital Markets analyst Keith Hinton initiated coverage on LivaNova PLC with a Hold rating and a price target of $81.
Amplitude Inc
Raymond James analyst Mark Cash initiated coverage on Amplitude Inc with a Strong Buy rating and a price target of $10.
Lionsgate Studios Corp
B. Riley Securities analyst Drew Crum initiated coverage on Lionsgate Studios Corp with a Neutral rating and a price target of $17.
Honeywell Aerospace Inc
Wells Fargo analyst David Strauss initiated coverage on Honeywell Aerospace Inc with an Equal-Weight rating and a price target of $250.
| Company | Analyst | Rating | Price Target | Previous Close |
|---|---|---|---|---|
| Abbott Laboratories | Baird (David Rescott) | Outperform | $121 | $90.74 |
| LivaNova PLC | Freedom Capital Markets (Keith Hinton) | Hold | $81 | $82.23 |
| Amplitude Inc | Raymond James (Mark Cash) | Strong Buy | $10 | $7.65 |
| Lionsgate Studios Corp | B. Riley Securities (Drew Crum) | Neutral | $17 | $15.31 |
| Honeywell Aerospace Inc | Wells Fargo (David Strauss) | Equal-Weight | $250 | $221.08 |
What specific catalysts might drive Abbott Laboratories to reach the $121 price target?
How could LivaNova's current product pipeline impact its future performance beyond the Hold rating?
What market trends are supporting the Strong Buy rating for Amplitude Inc despite its low share price?
18
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
